Turk Ilac ve Serumnayi (IST:TRILC) Margin of Safety % (DCF Earnings Based): N/A (As of Jul. 03, 2026)


IST:TRILC Turk Ilac ve Serum Sanayi IST:TRILC
61 GF Score
Price ₺1.18
GF Value ₺3.60
Valuation Possible Value Trap
! 11 Warning Signs
View Full Analysis

What is Turk Ilac ve Serumnayi Margin of Safety % (DCF Earnings Based)?

Margin of Safety % (DCF Earnings Based) = (Intrinsic Value: DCF (Earnings Based) - Current Price) / Intrinsic Value: DCF (Earnings Based).

Note: Discounted Earnings model is only suitable for predictable companies (Business Predictability Rank higher than 1-Star). If the company's Predictability Rank is 1-Star or Not Rated, result may not be accurate due to the low predictability of business and the data will not be stored into our database.

Turk Ilac ve Serumnayi's Predictability Rank is Not Rated. Thus, the DCF related results in the screener and portfolio will appear as zero and Margin of Safety % (DCF Earnings Based) is not calculated.

IST:TRILC vs ZTS, UTHR, VTRS: Margin of Safety % (DCF Earnings Based) Comparison

For the Drug Manufacturers - Specialty & Generic subindustry, Turk Ilac ve Serumnayi's Margin of Safety % (DCF Earnings Based), along with its competitors' market caps and Margin of Safety % (DCF Earnings Based) data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Turk Ilac ve Serumnayi Margin of Safety % (DCF Earnings Based) vs Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Turk Ilac ve Serumnayi's Margin of Safety % (DCF Earnings Based) distribution charts can be found below:

* The bar in red indicates where Turk Ilac ve Serumnayi's Margin of Safety % (DCF Earnings Based) falls into.


IST:TRILC
61GF Score
Turk Ilac ve Serum Sanayi IST:TRILC
Margin of Safety % (DCF Earnings Based) is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is Turk Ilac ve Serumnayi (IST:TRILC) Overvalued in 2026?

Based on GuruFocus' analysis, Turk Ilac ve Serumnayi stock appears to be undervalued. The current stock price of ₺1.18 is trading 67.2% below its estimated GF Value™ of ₺3.60. GuruFocus considers Turk Ilac ve Serumnayi to be Possible Value Trap.

Key valuation signals for IST:TRILC:

  • Margin of Safety % (DCF Earnings Based): N/A
  • GF Value™: ₺3.60 vs. price of ₺1.18 (67.2% below fair value)
  • GF Score™: 61/100 with 11 warning signs

No single metric tells the full story. See the IST:TRILC stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Turk Ilac ve Serumnayi Business Description

Address Bugduz Mahalle Enver Pasa Cadde, No: 8 Akyurt, Ankara, TUR, TR 06750
Turk Ilac ve Serum Sanayi is engaged in the production of human pharmaceuticals and vaccines.
61GF Score

Get the complete analysis for IST:TRILC

Margin of Safety % (DCF Earnings Based) is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

₺1.18
Price
₺3.60
GF Value